Monte Rosa Therapeutics I...

NASDAQ: GLUE · Real-Time Price · USD
4.45
0.10 (2.30%)
At close: Aug 15, 2025, 10:05 AM

Monte Rosa Therapeutics Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-7.06 -2.15 -3.31 -12.85
PEG Ratio
0.11 -0.15 -0.07 -0.14
PS Ratio
6.78 n/a n/a n/a
PB Ratio
2.30 1.62 1.32 2.73
P/FCF Ratio
13.50 -4.62 -3.41 -13.75
P/OCF Ratio
12.21 -6.63 -3.89 -16.01
OCF/S Ratio
0.56 n/a n/a n/a
Debt / Equity Ratio
0.19 0.26 0.17 n/a
Quick Ratio
2.40 5.07 10.75 20.96
Current Ratio
2.40 5.07 10.79 20.96
Asset Turnover
0.17 n/a n/a n/a
Interest Coverage
n/a n/a -29.86 n/a
Return on Equity
-0.33 -0.76 -0.4 -0.21
Return on Assets
-0.17 -0.45 -0.32 -0.2
Return on Invested Capital
-0.29 -0.55 -0.35 -0.21
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
0.89 n/a n/a n/a
Net Profit Margin
-0.96 n/a n/a n/a
Pretax Profit Margin
-0.93 n/a n/a n/a
Operating Profit Margin
-1.07 n/a n/a n/a
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
-0.97 n/a n/a n/a